Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

To XEN or to Phaco XEN?

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Glaucoma

Venue: Poster Village: Pod 2

First Author: : D.Gousia UK

Co Author(s): :    M. Tsatsos   U. Faridi                    

Abstract Details


To compare the effectiveness of XEN implant as a single procedure and XEN combined with cataract surgery and assess their complication rate.


Royal Eye Infirmary, Dorset County Hospital, UK


This is a prospective study over a period of 1.5 years, during which standardized procedures were performed by 2 surgeons. Patients were asked to stop their antiglaucoma medication 1 week preoperatively and ocular surface disease was treated.


39 patients underwent XEN implantation (GroupA) and 32 patients underwent cataract surgery combined with XEN (GroupB). Mean IOP preoperatively was 19.78mmHg in GroupA, reducing by 25%, 38.62% at 3 and 6 months postoperatively respectively. In GroupB mean IOP was 20.75mmHg preoperatively, which dropped by 25.49%, 25.78% at 3 and 6 months postoperatively respectively. Number of antiglaucoma medication preoperatively and at 6 months postoperatively decreased from 2.63 to 0.28 for GroupA and from 2.93 to 1 for GroupB. 12.82 % of patients in GroupA and 9.37 % of patients in GroupB required a further procedure in order to achieve target pressure.


IOP reduction was observed in both groups, with a greater reduction (p > 0.05) and less amount of antiglaucoma drops in Group A (p < 0.05). Complications and further management appeared slightly easier in Group B (p > 0.05).

Financial Disclosure:


Back to previous